OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 3
Data from combined, up to 2021-03-07.
| Vaccinated at 2021-03-07 (%) | Vaccinated at 2021-03-07 (n) | Population | Vaccinated at 2021-02-28 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 48.4% | 951,860 | 1,966,076 | 48.1% | 0.3% |
| Sex | Female | 48.5% | 508,095 | 1,047,270 | 48.2% | 0.3% |
| Male | 48.3% | 443,765 | 918,806 | 48.0% | 0.3% | |
| Ethnicity | White - British | 49.5% | 595,595 | 1,204,427 | 49.2% | 0.2% |
| White - Irish | 42.7% | 7,105 | 16,639 | 42.3% | 0.4% | |
| White - Any other White background | 39.0% | 16,835 | 43,148 | 38.6% | 0.5% | |
| Mixed - White and Black Caribbean | 38.9% | 833 | 2,142 | 37.6% | 1.3% | |
| Mixed - White and Black African | 35.8% | 406 | 1,134 | 35.2% | 0.6% | |
| Mixed - White and Asian | 39.8% | 518 | 1,302 | 38.7% | 1.1% | |
| Mixed - Any other mixed background | 38.8% | 882 | 2,275 | 38.2% | 0.6% | |
| Asian or Asian British - Indian | 39.1% | 9,961 | 25,501 | 38.6% | 0.4% | |
| Asian or Asian British - Pakistani | 38.7% | 4,095 | 10,570 | 37.4% | 1.4% | |
| Asian or Asian British - Bangladeshi | 40.8% | 1,190 | 2,919 | 38.8% | 1.9% | |
| Asian or Asian British - Any other Asian background | 36.5% | 4,165 | 11,410 | 36.0% | 0.6% | |
| Black or Black British - Caribbean | 34.5% | 3,934 | 11,410 | 33.1% | 1.3% | |
| Black or Black British - African | 29.8% | 2,387 | 8,015 | 28.2% | 1.6% | |
| Black or Black British - Any other Black background | 34.0% | 595 | 1,750 | 33.2% | 0.8% | |
| Other ethnic groups - Chinese | 36.2% | 1,148 | 3,171 | 35.5% | 0.7% | |
| Other ethnic groups - Any other ethnic group | 39.1% | 2,492 | 6,370 | 38.2% | 0.9% | |
| Patients with any other ethnicity code | 48.9% | 135,107 | 276,143 | 48.7% | 0.3% | |
| Ethnicity not stated | 47.9% | 5,628 | 11,739 | 47.6% | 0.4% | |
| Ethnicity not recorded | 48.8% | 158,893 | 325,899 | 48.4% | 0.3% | |
| Ethnicity (broad categories) | White | 49.0% | 619,549 | 1,264,228 | 48.8% | 0.3% |
| Mixed | 38.6% | 2,653 | 6,874 | 37.9% | 0.7% | |
| South Asian | 38.5% | 19,425 | 50,414 | 37.8% | 0.7% | |
| Black | 32.7% | 6,930 | 21,189 | 31.3% | 1.4% | |
| Other | 38.1% | 3,640 | 9,548 | 37.4% | 0.7% | |
| Unknown | 48.8% | 299,642 | 613,795 | 48.5% | 0.3% | |
| Index of Multiple Deprivation | 1 (most deprived) | 47.2% | 273,833 | 580,468 | 46.8% | 0.4% |
| 2 | 47.1% | 126,560 | 268,884 | 46.7% | 0.4% | |
| 3 | 49.0% | 167,622 | 341,789 | 48.8% | 0.3% | |
| 4 | 49.3% | 183,960 | 373,303 | 49.1% | 0.2% | |
| 5 (least deprived) | 49.7% | 191,940 | 386,337 | 49.5% | 0.2% | |
| Unknown | 51.8% | 7,917 | 15,274 | 51.5% | 0.4% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 49.1% | 567,357 | 1,156,127 | 48.7% | 0.3% |
| Patients with Immunosuppression | 48.9% | 41,685 | 85,309 | 48.5% | 0.3% | |
| Patients with CKD | 49.3% | 158,116 | 321,027 | 48.9% | 0.3% | |
| Patients who have Chronic Respiratory Disease | 49.9% | 111,699 | 223,678 | 49.5% | 0.4% | |
| Patients with Diabetes | 48.7% | 178,290 | 366,072 | 48.3% | 0.4% | |
| Patients with Chronic Liver disease | 48.2% | 25,060 | 51,954 | 47.9% | 0.4% | |
| Patients with CNS Disease (including Stroke/TIA) | 51.3% | 108,675 | 211,911 | 50.9% | 0.4% | |
| Patients with Chronic heart disease | 49.4% | 290,976 | 588,749 | 49.1% | 0.3% | |
| Patients with Asplenia or Dysfunction of the Spleen | 49.2% | 8,414 | 17,108 | 48.8% | 0.4% | |
| Patients with Wider Learning Disability | 56.2% | 1,309 | 2,331 | 54.7% | 1.5% | |
| Patients with Severe Mental Health | 50.6% | 7,966 | 15,750 | 49.7% | 0.8% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 49.3% | 151,263 | 306,628 | 48.8% | 0.5% |
| Patients with Morbid Obesity | 51.2% | 24,423 | 47,663 | 50.7% | 0.5% | |
| Patients who are pregnant | 48.5% | 112 | 231 | 48.5% | 0.0% |